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Biofilm is a complexmicrobial community highly resistant to antimicrobials.The formation of biofilms in biotic and abiotic surfaces
is associated with high rates of morbidity and mortality in hospitalized patients. New alternatives for controlling infections have
been proposed focusing on the therapeutic properties of medicinal plants and their antimicrobial effects. In the present study
the antimicrobial and antibiofilm activities of 8 methanolic plant extracts were evaluated against clinical isolated microorganisms.
Preliminary screening by diffusion well assay showed the antimicrobial activity of Prosopis laevigata, Opuntia ficus-indica, and
Gutierrezia microcephala. The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) were
determined ranging from 0.7 to >15mg/mL.The specific biofilm formation index (SBF) was evaluated before and after the addition
of plant extracts (MBC × 0.75). Opuntia ficus-indica caused the major reduction on SBF in dose-dependent manner. Cytotoxic
activity of plant extracts was determined using brine shrimp lethality test (Artemia salina L.). Lethal Dose concentration (LD
50
values) of the plant extractswas calculated. LD
50
values forP. laevigata and G.microcephalawere 141.6 and 323.3 𝜇g/mL, respectively,
while O. ficus-indica showed a slight lethality with 939.2𝜇g/mL. Phytochemical analyses reveal the presence of flavonoids, tannins,
and coumarines.
1. Introduction
Microbial biofilms are communities of bacteria, embedded
in a self-producing matrix, forming on living and nonliving
solid surfaces [1]. Biofilm-associated cells have the ability to
adhere irreversibly on a wide variety of surfaces, including
living tissues and indwelling medical devices as catheters,
valves, prosthesis, and so forth [2].
They are considered an important virulence factor that
causes persistent chronic and recurrent infections; they are
highly resistant to antibiotics and host immune defenses
[3]. Bacteria protected within biofilm exopolysaccharides
are up to 1,000 times more resistant to antibiotics than
planktonic cells (free-floating) [4], which generates serious
consequences for therapy and severely complicates treatment
options [5]. An estimated 75% of bacterial infections involve
biofilms that are protected by an extracellular matrix [6].
Biofilm resistance is due to several reasons, like restricted
diffusion of antibiotics into biofilm matrix, expression of
multidrug efflux pumps, type IV secretion systems, decreased
permeability, and the action of antibiotic-modifying enzymes
[7]. The increased biofilm resistance to conventional treat-
ments enhances the need to develop new control strategies
[8].
Biofilm inhibition is considered as major drug target for
the treatment of various bacterial and fungal infections, and
pharmacological development of this drugs is now exten-
sively studied [9]. In recent years, several green nonlethal
strategies for biofilm control have been developed, because
the mode of action of these novel antibiofilm agents is
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Table 1: Overview of the collected plants used in this investigation.
Scientific name Common name Family Part used Voucher number
Sophora secundiflora (Ortega) Lag. Ex
DC. Mountain laurel Fabaceae Aerial parts 027770
Sphaeralcea ambigua A. Gray Desert globemallow Malvaceae Bark 027771
Prosopis laevigata (Humb. et Bonpl. ex
Willd) M.C. Johnston Smooth mesquite Fabaceae Bark and leaves 027772
Opuntia ficus-indicaMill. Nopal cactus Cactaceae Cladode 027773
Marrubium vulgare L. White horehound Lamiaceae Aerial parts 027774
Scutellaria drummondii Benth Drummond’s skullcap Lamiaceae Aerial parts 027775
Nothoscordum bivalve Britton. Crowpoison Alliaceae Bulb 027776
Gutierrezia microcephala (DC.) Gray Sticky snakeweed Asteraceae Aerial parts 027777
much less susceptible to the emergence of resistance [10].
However although they are promising strategies, they have
disadvantages because none have been totally effective [5].
One promising alternative is the search for naturally
occurring compounds of plant origin capable of blocking
biofilm formation [11]. Historically, plant extracts and their
biologically active compounds have been a valuable source
of natural products, which have played a central role in the
prevention and treatment of diseases, helping to maintain
human health [12]. Furthermore, they are widely accepted
due to the perception that they are safe and have a long history
of use in folk medicine to cure diseases and illnesses since
ancient times [13].
Considering the above and based on previous results
obtained in our laboratory, in the present study we propose
to evaluate the antibiofilm effect of 8 extracts plants against 5
clinical isolated pathogens.
2. Material and Methods
2.1. Plant Material. Fresh and healthy plants growing wild
around theCasablanca community, located in SantaCatarina,
Nuevo Leo´n, Mexico (25∘39󸀠11.33󸀠󸀠N 100∘42󸀠41.09󸀠󸀠W), were
collected between March and April 2014. Voucher samples
were deposited at the herbariumof the Botanical Department
of Biological Sciences School, Universidad Auto´noma de
Nuevo Leo´n, for identification purposes. Collected plants
(Table 1) were washed thoroughly in tap water, followed by
successive washing in distilled water. Washed plants were cut
into small pieces and air-dried at room temperature (25±2∘C)
under shade. Finally, dried material was grounded to coarse
powder in amanual grainmill and stored in plastic containers
for further analysis.
2.2. Bacterial Strains and Culture Conditions. The microor-
ganisms used in this study were 5 nosocomial pathogens,
4 Gram-negative (Klebsiella pneumoniae, Enterococcus fae-
calis, Escherichia coli, and Stenotrophomonas maltophilia)
and 1 Gram-positive (Staphylococcus aureus). All strain were
kindly provided by Dra. Elvira Garza Gomza´lez, School of
Medicine,UANL. Strainsweremaintained inMueller-Hinton
(MH) agar (Difco) at 4∘C. Active cultures were obtained by
inoculation of a loopful of each strain into separated 5mL
MH broth (Difco) and incubated for 18 h at 37∘C.
2.3. Preparation of Plant Extracts. Extracts were prepared
following the methodology proposed by Sa´nchez et al. [14],
withminormodifications. Briefly, one hundred grams (100 g)
of dried plant material was soaked with 500mL of methanol
for 24 h at room temperature (25 ± 2∘C), under occasional
shaking. Extractionwas repeated three times, and the extracts
obtained were combined and filtered throughWhatman filter
paper number 1. After that, theywere concentrated to dryness
under reduced pressure using a rotary evaporator at 45∘C.
Stock solutions (200mg/mL) were prepared in methanol and
stored at 4∘C in the dark for further experiments.
2.4. Qualitative Phytochemical Screening. The extracts were
subjected to standard phytochemical tests in order to evaluate
their chemical composition for different active constituents;
for this extracts (3–5mg/mL) they were separately suspended
in 1mL of absolute ethanol or distilled water (carbohydrate
determination) using clean test tubes.
2.5. Bayer’s Test for Unsaturation. In this case aqueous 1%
KMnO
4
was added dropwise to the extract solution. A
positive test was evidenced by the disappearance of the
purple color of KMnO
4




2.6. Detection of Triterpenes/Steroids (Liebermann-Burchard
Reagent). One mL of acetic anhydride and 5 drops of con-




) were added to the extract.
A color change from violet to blue confirms the presence of
steroids [16] and formation of blue-green ring indicated the
presence of terpenoids [17].
2.7. Coumarins. Three mL of 2N NaOH was added to 2mL
of aqueous extract. Formation of yellow color indicated the
presence of coumarins. Confirmation test was performed by
adding 1mL of 5N HCl; in this case a colorless solution
formed at the upper layer is considered positive [18].
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2.8. Alkaloids. Ethanolic extracts (20 𝜇L) were applied on
TLC plates (Silica Gel 60G, 5 × 10 cm) and eluted using
toluene-ethyl acetate-diethylamine (70 : 20 : 10) as solvent
system. Alkaloids were detected after spraying Dragendorff ’s
reagent as orange-brown spots on TLC plates [19].
2.9. Screening for Sesquiterpene Lactones. The Baljet reaction
(1% Picric acid in 10% sodium hydroxide) was used to detect
sesquiterpene lactones in the extracts. Reagents were mixed
at a 1 : 1 ratio and added to 1mL of extracts (2-3mg). The
transformation of the sodium picrate solution’s yellow color
to orange-red color confirmed the positive reaction [20].
2.10. Test for Quinones. Extracts suspended in ethanol (1mL)
were treated with 1mL of concentrated sulfuric acid. Forma-
tion of red color shows the presence of quinones [21].
2.11. Carboxyl Group. The presence of carboxyl groups was
evidenced by adding 10 drops of 10% sodium bicarbonate
solution; visible bubbles of carbon dioxide were considered
a positive reaction [21].
2.12. Test for Tannins. Extracts were treated with 1mL of 5%
ferric chloride which was added.The presence of tannins was
indicated by the formation of bluish black or greenish black
precipitate [22].
2.13. Shinoda Test. Few fragments of magnesium metal rib-
bon (3-4 pieces) were added to 1mL of ethanolic extract,
followed by dropwise addition of concentrated hydrochloric
acid. Formation of pink or red color indicated the presence of
flavonoids [23].
2.14. Saponin. Two mL of distilled water was added to
extracts suspended in ethanol andwas shaken vigorously.The
formation of copious foam layer indicates the presence of
saponins [23].
2.15. Carbohydrates. For carbohydrates test, extracts (10mg)
were suspended in 1mL of distilled water; afterward 2mL of
0.2% anthrone reagent and 5 drops of concentrated sulfuric
acid were added. Dark green color showed the presence of
carbohydrates [21].
2.16. Evaluation of Antimicrobial Activity. Antimicrobial
activity of plant extracts was performed using the agar-well
diffusion bioassay. Briefly, 100 𝜇L of fresh culture (approx-
imately 106 CFU/mL) was uniformly spread onto Mueller-
Hinton agar (MHA) plates by sterile Driglasky loop. Then,
inoculated plates were allowed to dry at room temperature
for 20min. After that, wells of 6mm in diameter were made
in the agar using a sterilized cup-borer and 100 𝜇L of each
extract was poured in thewells.Methanolwas used as control.
Plates were incubated at 37∘C for 18 h. Antibacterial activity
was evidenced by the presence of clear inhibition zone around
each well. The diameter of this zone was measured and
recorded [14].
2.17. Assessment of Minimum Inhibitory Concentration (MIC)
and Minimum Bactericidal Concentration (MBC). The MIC
and MBC were determined on plant extracts that showed
antimicrobial activity, by a broth microdilution method
proposed by Novy et al. [24], with minor modifications.
Briefly, 100 𝜇L ofMueller-Hinton Broth (Difco) plus different
concentrations of plant extracts was prepared and transferred
to each microplate well to obtain dilutions of the active
extract, ranging from 1.0 to 25mg/mL. Then, 10 𝜇L of a
fresh culture (final concentration of 1 × 106 CFU/mL) of test
organisms was added.Microplates were incubated at 37∘C for
24 h [25]. MIC was defined as the lowest concentration of the
extract that restricted the visible growth of microorganism
tested.
To determineMBC, 100 𝜇L from eachwell that showedno
visible growth was reinoculated on MH agar plates; then the
plates were incubated at 37∘C for 24 h. MBC was defined as
the lowest extract concentration showingnobacterial growth.
Methanol was used as blank and tetracycline (Sigma Aldrich,
Mexico City, Mexico) as positive control. Once the MBC
was recorded, the sublethal activity on bacterial growth was
determined; for this, concentrations of 75, 50, and 25% of
MBC were tested in a 96-well microplate and the counts
of microbial cells were done by plate count technique, as
previously mentioned.
2.18. Biofilm Formation Inhibition. The effect of extracts on
biofilm formation was evaluated in 96-well polystyrene flat-
bottom plates [26]. Briefly, 300 𝜇L of inoculated fresh trypti-
case soy yeast broth (TSY) (final concentration 106 CFU/mL)
was aliquoted into each well of microplate and cultured in
presence of sublethal concentrations (75, 50, and 25% of
MBC) previously determined. Wells containing medium and
those without extracts and only with methanol were used as
controls. Plates were incubated at 37∘C for 48 h. After incu-
bation, supernatant was removed and each well was washed
thoroughly with sterile distilled water to remove free-floating
cells; thereafter plates were air-dried for 30min and the
biofilm formed was stained during 15min at room temper-
ature with 0.1% aqueous solution of crystal violet. Following
incubation, the excess of stain was removed washing the plate
three times with sterile distilled water. Finally, the dye bound
to the cells was solubilized by adding 250 𝜇L of 95% ethanol
to each well and after 15min of incubation, absorbance was
measured using microplate reader at a wavelength of 570 nm.
Biofilm determination was made using the formula SBF =
(AB − CW)/G, where SBF is the specific biofilm formation,
AB is theOD570 nmof the attached and stained bacteria, CW
is the OD570 nm of the stained control wells containing only
bacteria-free medium, and G is the OD630 nm of cell growth
in broth [27].
2.19. Toxicity Bioassay. Brine shrimp (Artemia salina) lethal-
ity bioassay was carried out in accordance with methodology
proposed by Meyer et al. [28] to determine the toxicity of
extract plants. For this, brine shrimps cysts were hatched in
a shallow rectangular container, which was divided into two
unequal compartments, filled with sterile artificial seawater
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Table 2: Diameter of inhibition zone of methanolic extracts against clinical isolated bacteria.
Plant Inhibition zone (cm)
K. pneumoniae E. faecalis E. coli S. maltophilia S. aureus
S. secundiflora NI NI NI NI 2.1 ± 0.3
S. ambigua NI NI NI NI 1.2 ± 0.1
P. laevigata 1.4 ± 0.3 1.7 ± 0.3 1.5 ± 0.3 NI 2.6 ± 0.3
O. ficus-indica 1.7 ± 0.1 1.5 ± 0.1 1.6 ± 0.3 NI 1.6 ± 0.3
M. vulgare NI 0.7 ± 0.01 NI NI 1.8 ± 0.2
S. drummondii NI 0.6 ± 0.01 NI NI 1.7 ± 0.2
N. bivalve NI NI NI NI NI
G. microcephala NI NI 1.6 ± 0.1 NI 2.3 ± 0.2
Values are means ± standard deviations. NI: no inhibition.
(prepared by dissolving sea salt 38 g/L and adjusted to pH 8.5
using 1N NaOH) under constant aeration and proper light.
Cyst (ca. 50mg) was sprinkled into the larger compartment,
which was darkened, while the smaller was illuminated. Yeast
solution 0.06%was added to the hatching chamber to feed the
larvae. After 48 h the phototropic free nauplii were collected
from the lighted side.
Lethality bioassay was performed using 10 collected nau-
plii, which were transferred into vials contained tested crude
plant extract, at 10, 100, and 1000 𝜇g/mL, and artificial seawa-
ter. Appropriate quantities of methanol were used as negative
control.
After 24 h of incubation, live nauplii were counted and
the LC
50
values were estimated using a Probit regression
analysis. Extracts giving LC
50
values above 1000𝜇g/mL were
considered nontoxic.
2.20. Statistical Analysis. All experimental results were
expressed as mean ± standard deviation (SD) for analysis
performed in duplicate at least three times. Statistical analysis
of the data was performed by Analysis of Variance (ANOVA)
and mean comparison using Student’s 𝑡-test, using SPSS
software version 17.0. The LC
50
for bioassay with A. salina
was determined according to the Probit statistical method.
𝑃 < 0.05 was considered statistically significant.
3. Results and Discussion
A total of 8 methanolic plant extracts were tested against 5
clinical bacterial isolates.Methanol was selected as extraction
solvent, because it is one of the best solvents used for the
extraction of antimicrobial substances [29, 30]. Moreover,
methanol polarity ensured the extraction of polar and mod-
erately polar active compounds from plants against microor-
ganisms like terpenoids, tannins, flavones, and polyphenols
[31].
Results of preliminary antimicrobial tests, performed by
the well diffusion method, were quite variable between each
plant extract ranging from 0 to 2.8 cm (Table 2). P. laevigata
extract was active against all the clinical isolates, while N.
bivalve bulb did not show activity against anymicroorganism.
The highest diameter of inhibition was obtained with P.
laevigata extract (2.8 ± 0.5 cm), against S. aureus strain,
followed byG. microcephala (2.3±0.2 cm) andO. ficus-indica
(1.6 ± 0.3 cm) also against S. aureus. Meanwhile E. coli was
less susceptible to these extracts showing diameters of 1.7 ±
0.3, 1.4 ± 0.1, and 1.6 ± 0.1 cm, respectively. K. pneumoniae
and E. faecalis were more resistant to the extracts, only
inhibited by P. laevigata and O. ficus-indica with inhibition
zones ranging from 0.7 ± 0.08 to 1.3 ± 0.2; on the other
hand, S. maltophiliawas the onlymicroorganism that was not
inhibited by the extracts.
However, the well diffusion assay is considered a qual-
itative technique and is mainly used for selecting extracts
with antimicrobial activity, mostly when diameters zones
of inhibition are ≥10mm [32]. It is important to recognize
that the size of inhibition zones of different extracts could
be due to the compounds polarity obtained, since a more
diffusible but less active extract could give a bigger diameter
of inhibition than a nondiffusible butmore active extract [33].
Minimum inhibitory concentration (MIC) results are
comparable to those obtained in the agar-well diffusion
technique, because the lowest MIC were obtained using
the extracts showing the best antimicrobial activity (data
not shown). Meanwhile results of minimum bactericidal
concentrations (MBC) are listed in Table 3, where P. laevigata
extract had the lowest MBC with a value of 2mg/mL for E.
coli, 2.8mg/mL for E. faecalis, 3.8mg/mL for K. pneumoniae,
and 0.7mg/mL for S. aureus. Extracts and O. ficus-indica got
the highest CMB ranging from 1.0 to ≥15mg/mL. CMBs of
G. microcephala were 2.8 and 8.3mg/mL against S. aureus
and E. coli, respectively. MBC results show that S. aureus
was the more sensitive microorganism, being inhibited for 8
methanolic extracts, while S. maltophilia was not inhibited
by any extract. Broadly, our results agree with previous
reports, which mention greater activity of extracts towards
Gram-positive microorganisms compared to Gram-negative
microorganisms [34]. These differences can probably be
attributed to the structural and compositional differences
in the cell wall and membranes [25]. The Gram-negative
bacteria have an outer membrane that serves as barrier for
many molecules; also, the presence of efflux pump system
has been demonstrated, which can mediate the resistance
to natural compounds [35]. Escherichia coli was the most
susceptible of the Gram-negative bacteria; this finding also
agrees with previous reports [36].
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Table 3: Minimum bactericidal concentration (MBC) of methanolic extracts against clinical isolated bacteria.
Plant MBC (mg/mL)
K. pneumoniae E. faecalis E. coli S. maltophilia S. aureus
S. secundiflora NE NE NE NE 9.1 ± 0.4
S. ambigua NE NE NE NE >15
P. laevigata 3.8 ± 0.1 2.7 ± 0.1 1.5 ± 0.2 NE 0.7 ± 0.01
O. ficus-indica >15 >15 4.0 ± 0.3 NE 1.0 ± 0.2
M. vulgare NE 0.7 ± 0.01 NE NE 3.9 ± 0.3
S. drummondii NE 0.6 ± 0.01 NE NE 7.3 ± 0.2
N. bivalve NE NE NE NE NE
G. microcephala NE NE 8.3 ± 0.2 NE 2.8 ± 0.3
Values are means ± standard deviations. NE: not evaluated.
Table 4: Phytochemical screening results of selected methanolic extracts.
Compounds P. laevigata O. ficus-indica G. microcephala
Unsaturation — ++ ++
Triterpenes/steroids ++/Steroids ++/Triterpenes +++/Triterpenes
Coumarins +++ + +++
Alkaloids +++ — —
Sesquiterpene lactones — — ++
Quinones — + +
Carboxyl group — — —
Tannins +++ ++ +++
Saponins — — —
Carbohydrates ++ +++ —
Flavonoids ++ + ++
+: low intensity reaction, ++: medium intensity reaction, and +++: strong intensity reaction.
According to the previously mentioned results, it was
decided to select 3 plant extracts (P. laevigata, O. ficus-indica,
andG.microcephala)whichwere active against E. coli (Gram-
negative) and S. aureus (Gram-positive); moreover these
extracts showed the lowest MBC.
Phytochemical screening results of selected plant extracts
are summarized in Table 4 and show the presence of
different functional groups. Coumarins, alkaloids, tannins,
and flavonoids were found in P. laevigata extract. Similar
compounds have been reported in different species of this
plant like P. juliflora, where the presence of tannins, phe-
nolics, flavonoids, steroids, terpenes, and alkaloids has been
reported [37]. Likewise, reports of Prosopis spp. mentioned
that this plant contains harmine, prosopine which is an
alkaloid reported in several papers, tyramine, prosopinine,
and juliflorine, which are alkaloids that intercalate into DNA
and could explain the antimicrobial activity of this extract
[31, 38].
In case of O. ficus-indica, results indicate the presence
of triterpenes, coumarins, quinones, tannins, carbohydrates,
and flavonoids; flavonoids cause bacterial death by inhibiting
DNA or RNA synthesis and tannins including possible
inhibition of extracellular microbial enzymes [39, 40].
Meanwhile, triterpenes, coumarins, quinones, tannins,
flavonoids, and sesquiterpene lactones were found in G.
microcephala. According to Go¨ren et al. [41] sesquiterpene
lactones are the main secondary metabolite responsible
for the antimicrobial activity in Asteraceae family. While
McDaniel and Ross [42] report the presence of alkaloids and
saponins conferring some toxicity at this plant.
Biofilm formation inhibition results by addition of subin-
hibitory concentrations (75, 50, and 25% of MBC) of plant
extracts against E. coli and S. aureus indicated that the
obtained effect was dose-dependent. The best biofilm reduc-
tion is observed in higher concentrations of the extracts (75%
of WBC). Similar results were reported by Issac Abraham
et al. [43], who reported that methanolic caper extract
significantly inhibited biofilm formation and EPS production
in E. coli, Serratia marcescens, Pseudomonas aeruginosa, and
Proteus mirabilis. As well Ravichandiran et al. [44] reported
that ethanolic extract of the bark of Melia dubia caused
a strong suppression of hemolysis, swarming motility, and
biofilm formation in E. coli. Results of the effect of concentra-
tions corresponding to 75 and 50% ofMBC caused significant
(𝑃 < 0.05) reduction of the specific biofilm formation (SBF)
of E. coli (Figure 1) from approximately 3 (strong biofilm) to
levels of 0.2 (weak biofilm, 75% MBC) and 1.2 (moderated
biofilm, 50% MBC). The SBF classification categories were
mentioned by Mittal et al. [45] who mention that strong
biofilm producers (SBF index > 2.00), intermediate biofilm
producers (SBF index between 1 and 2), andweak biofilmpro-
ducers (SBF index < 1.00). Similar results were obtained with
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Figure 1: Inhibition of biofilm formation by different concentrations
of plant extracts against E. coli.
S. aureus (data not shown). Inhibition of biofilm formation
can be explained by the presence of flavonoids, previously
reported such as quercetin, kaempferol, naringenin, and
apigenin, which are capable of reducing biofilm synthesis
because they can suppress the activity of the autoinducer-2
responsible for cell-to-cell communication [46].
A. salina bioassay is used to evaluate the toxicity of plant
extracts and has the advantage of being inexpensive, reliable,
and reproducible [47]. In a previous study, Ahmed et al.
[48] determined the toxicity of methanol extract of Prosopis
spicigera reporting 60% survived nauplii at 100 𝜇g/mL which
is consistent with the results obtained in this work, because
LD
50
obtained of P. laevigata was 141.6 𝜇g/mL indicating
that the extract is moderately toxic; this may be due to
the presence of certain bioactive compounds which may be
related to the antibacterial activity. For G. microcephala was
moderately toxic with LD
50
of 323.3 𝜇g/mL, some studies
mentioned that this toxicity may be due to the presence of
saponins, essential oils, mono- and sesquiterpenes, tannins,
and alkaloids [42, 49]. Results of O. ficus-indica indicate
slight toxicity (939.2 𝜇g/mL); this is consistent as reported by
De´ciga-Campos et al. [50]. Low toxicity could be explained
with the common use of this plant in traditional medicine.
Furthermore, in vivo and in vitro experiments of cladodes
and fruits show a beneficial effect on health due to the
presence of flavonoids, which have health-related properties,
which are based in their antioxidant activity [51, 52].
4. Conclusions
Some of the plant extracts evaluated in present research
had potential antimicrobial and antibiofilm activities against
isolated nosocomial bacteria, which can be an alternative to
control the formation of microbial biofilms or can be used as
model to the search for new drugs.
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